Literature DB >> 15599784

Emergence of methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin genes in central Europe.

W Witte1, C Braulke, C Cuny, B Strommenger, G Werner, D Heuck, U Jappe, C Wendt, H-J Linde, D Harmsen.   

Abstract

The aim of the present study was to investigate strains of methicillin-resistant Staphylococcus aureus (MRSA) for the presence of the lukS-lukF determinant of Panton-Valentine leukocidin and to further characterize strains found to contain the genes. During the past 2 years, MRSA containing the lukS-lukF genes for Panton-Valentine leukocidin, particularly those emerging outside of hospitals, have become of interest. MRSA strains sent to the national reference center in Germany were investigated for lukS-lukF by polymerase chain reaction (PCR). If the presence of lukS-lukF was demonstrated, strains were further characterized by molecular typing (determination of SmaI pattern, spa sequence, and multilocus sequence type), PCR demonstration of resistance genes, and characterization of the SCCmec element. Since the end of 2002, MRSA containing Panton-Valentine leukocidin genes have been demonstrated as the causative agent of 28 cases of infection (9 community-acquired cases, 19 sporadic nosocomial cases) in different areas of Germany. Twenty-seven of these 28 isolates exhibited a unique pattern of genomic typing: all exhibited multilocus sequence type 80, spa sequence type 44, and a SmaI macrorestriction pattern that corresponds to a community-acquired strain of MRSA from France and Switzerland. In addition to resistance to oxacillin, the strains exhibited resistance to ciprofloxacin, tetracycline (tetM), and fusidic acid, the last of which is encoded by the far-1 gene. The far-1 gene was shown to be located on the plasmid. One isolate corresponded to community MRSA (cMRSA) of multilocus sequence type 1 from the USA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15599784     DOI: 10.1007/s10096-004-1262-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  25 in total

Review 1.  Methicillin-resistant Staphylococcal aureus evolution in Australia over 35 years.

Authors:  J D Turnidge; J M Bell
Journal:  Microb Drug Resist       Date:  2000       Impact factor: 3.431

2.  Community-acquired Methicillin-resistant Staphylococcus aureus: Epidemiology and Potential Virulence Factors.

Authors:  Jose M. Eguia; Henry F. Chambers
Journal:  Curr Infect Dis Rep       Date:  2003-12       Impact factor: 3.725

3.  Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management.

Authors:  Dag Harmsen; Heike Claus; Wolfgang Witte; Jörg Rothgänger; Hermann Claus; Doris Turnwald; Ulrich Vogel
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

4.  Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community.

Authors:  Keiko Okuma; Kozue Iwakawa; John D Turnidge; Warren B Grubb; Jan M Bell; Frances G O'Brien; Geoffrey W Coombs; John W Pearman; Fred C Tenover; Maria Kapi; Chuntima Tiensasitorn; Teruyo Ito; Keiichi Hiramatsu
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

5.  Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998.

Authors:  T S Naimi; K H LeDell; D J Boxrud; A V Groom; C D Steward; S K Johnson; J M Besser; C O'Boyle; R N Danila; J E Cheek; M T Osterholm; K A Moore; K E Smith
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

6.  Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia.

Authors:  G Lina; Y Piémont; F Godail-Gamot; M Bes; M O Peter; V Gauduchon; F Vandenesch; J Etienne
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

7.  Genetic characterization of the fusidic acid and cadmium resistance determinants of Staphylococcus aureus plasmid pUB101.

Authors:  Frances G O'Brien; Christopher Price; Warren B Grubb; John E Gustafson
Journal:  J Antimicrob Chemother       Date:  2002-09       Impact factor: 5.790

8.  New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci.

Authors:  A Huletsky; R Giroux; V Rossbach; M Gagnon; M Vaillancourt; M Bernier; F Gagnon; K Truchon; M Bastien; F J Picard; A van Belkum; M Ouellette; P H Roy; M G Bergeron
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

9.  Molecular analysis of fusidic acid resistance in Staphylococcus aureus.

Authors:  Silke Besier; Albrecht Ludwig; Volker Brade; Thomas A Wichelhaus
Journal:  Mol Microbiol       Date:  2003-01       Impact factor: 3.501

10.  Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors.

Authors:  Cassandra D Salgado; Barry M Farr; David P Calfee
Journal:  Clin Infect Dis       Date:  2003-01-03       Impact factor: 9.079

View more
  45 in total

1.  Heterogeneity of methicillin-susceptible Staphylococcus aureus strains at a German University Hospital implicates the circulating-strain pool as a potential source of emerging methicillin-resistant S. aureus clones.

Authors:  F Layer; B Ghebremedhin; W König; B König
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  Multilocus sequence typing of methicillin-resistant Staphylococcus aureus from an area of low endemicity by real-time PCR.

Authors:  Carolina Berglund; Paula Mölling; Lennart Sjöberg; Bo Söderquist
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 3.  Antimicrobial agents for treatment of serious infections caused by resistant Staphylococcus aureus and enterococci.

Authors:  G M Eliopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

4.  New strains of community-acquired methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin causing an outbreak of severe soft tissue infection in a football team.

Authors:  M Müller-Premru; B Strommenger; N Alikadic; W Witte; A W Friedrich; K Seme; N Svent Kucina; D Smrke; V Spik; M Gubina
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

5.  Multiple cases of familial transmission of community-acquired methicillin-resistant Staphylococcus aureus.

Authors:  X W Huijsdens; M G van Santen-Verheuvel; E Spalburg; M E O C Heck; G N Pluister; B A Eijkelkamp; A J de Neeling; W J B Wannet
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

6.  Community-acquired pneumonia and bacteremia caused by an unusual methicillin-resistant Staphylococcus aureus (MRSA) strain with sequence type 36, staphylococcal cassette chromosome mec type IV and Panton-Valentine leukocidin genes.

Authors:  B Söderquist; C Berglund; K Strålin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-09       Impact factor: 3.267

7.  Longitudinal study of the molecular epidemiology of methicillin-resistant Staphylococcus aureus at a university hospital.

Authors:  Sabine Petersdorf; Klaus Oberdorfer; Constanze Wendt
Journal:  J Clin Microbiol       Date:  2006-10-04       Impact factor: 5.948

8.  Favorable outcome of pneumonia due to Panton-Valentine leukocidin-producing Staphylococcus aureus associated with hematogenous origin and absence of flu-like illness.

Authors:  C Alonso-Tarrés; M L Villegas; F J de Gispert; M C Cortés-Lletget; A Rovira Plarromaní; J Etienne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

9.  Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus.

Authors:  Jörg J Ruhe; Anupama Menon
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

10.  Epidemiology of European community-associated methicillin-resistant Staphylococcus aureus clonal complex 80 type IV strains isolated in Denmark from 1993 to 2004.

Authors:  A R Larsen; S Böcher; M Stegger; R Goering; L V Pallesen; R Skov
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.